KLRS – kalaris therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Kalaris Therapeutics (KLRS) is now covered by Morgan Stanley. They set an "overweight" rating on the stock.
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
Kalaris Therapeutics (KLRS) was upgraded by Wall Street Zen from "sel
Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at Wall Stre
Kalaris Therapeutics (NASDAQ:KLRS) was downgraded by analysts at Wall St
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.